These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 2901784)

  • 1. Effect of acid inhibition on Campylobacter pylori.
    Blanco M; Pajares JM; Jimenez ML; Lopez-Brea M
    Scand J Gastroenterol Suppl; 1988; 142():107-9. PubMed ID: 2901784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is Campylobacter pylori the pathogenic agent in gastritis and peptic ulcer?].
    Vráblik V; Trupl J; Pavlovic M; Horváth A; Nespor V
    Vnitr Lek; 1989 Jul; 35(7):672-8. PubMed ID: 2800373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of antibiotics in Campylobacter pylori associated peptic ulcer disease.
    Bayerdörffer E; Ottenjann R
    Scand J Gastroenterol Suppl; 1988; 142():93-100. PubMed ID: 3047854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease.
    Kamada T; Hata J; Kusunoki H; Sugiu K; Ito M; Tanaka S; Kawamura Y; Chayama K; Haruma K
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():99-104. PubMed ID: 15943855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Campylobacter pylori and its role in peptic ulcer disease.
    Tytgat GN; Rauws EA
    Gastroenterol Clin North Am; 1990 Mar; 19(1):183-96. PubMed ID: 2184128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Campylobacter pylori in duodenal and gastric mucosa--relationship to inflammation.
    Johnston BJ; Reed PI; Ali MH
    Scand J Gastroenterol Suppl; 1988; 142():69-75. PubMed ID: 3166535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Campylobacter pylori infection in gastric and duodenal ulcer.
    Andreica V; Sască N; Dumitraşcu D; Drăghici A; Pascu O; Sască C; Gorgan V; Ban A
    Med Interne; 1988; 26(4):297-303. PubMed ID: 3244989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Campylobacter pylori and gastroduodenal pathology in children].
    Oderda G; Forni M; Tavassoli K; Ansaldi N
    Pediatr Med Chir; 1988; 10(1):19-23. PubMed ID: 3287348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Campylobacter pylori and treatment of duodenal ulcer].
    Zelenková J; Toman R; Bielaszewská M; Hanika J; Zeman V
    Vnitr Lek; 1990 Jun; 36(6):573-9. PubMed ID: 2219764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of Campylobacter pylori in duodenal ulceration treated with an H2-antagonist.
    Ho J; Hui WM; Ng I; Lam SK
    Aliment Pharmacol Ther; 1989 Jun; 3(3):315-20. PubMed ID: 2577695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Campylobacter pyloridis in peptic ulcer].
    Aruin LI; Smotrova IA; Il'chenko AA
    Arkh Patol; 1988; 50(2):13-8. PubMed ID: 3377694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Campylobacter pylori, gastritis and ulcer disease. Microbiological, histological and serological studies].
    Schaub N; Stalder H; Stalder GA; Marbet UA; Vögtlin J; Affolter H; Wegmann W; Vischer WA; Zingel O; Tanner K
    Schweiz Med Wochenschr; 1988 Mar; 118(9):293-301. PubMed ID: 3282302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of famotidine and ranitidine on prostaglandin E2 (PGE2) content of fundic and duodenal mucosa in duodenal ulcer patients.
    Lezoche E; Vagni V; D'Alessandro MD; Mariani P; Carlei F; Lomanto D; Nardovino M; Martelli A; Speranza V
    Drugs Exp Clin Res; 1987; 13(10):655-8. PubMed ID: 2892658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Campylobacter pylori, gastritis and peptic ulcer].
    Hirschl AM; Stanek G; Rotter M; Pötzi R; Gangl A; Hentschel E; Schütze K; Holzner HJ; Nemec H
    Wien Klin Wochenschr; 1987 Jul; 99(14):493-7. PubMed ID: 3630180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients.
    Jhala NC; McFarland MM; Brightman SA; Morale B; Rubin W; Atkinson BF
    Am J Gastroenterol; 1995 Oct; 90(10):1824-8. PubMed ID: 7572902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.
    Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Uchida T; Fujiwara Y; Arakawa T
    Int J Clin Pharmacol Res; 2005; 25(4):187-94. PubMed ID: 16402635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of famotidine with cimetidine and ranitidine.
    Berardi RR; Tankanow RM; Nostrant TT
    Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibacterial treatment of Campylobacter pylori-associated gastritis and peptic ulcer].
    Andreasen JJ; Ringsdal VS
    Ugeskr Laeger; 1989 Apr; 151(17):1030-3. PubMed ID: 2734863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Famotidine. The ACG Committee on FDA-Related Matters with primary authorship by G. Friedman. American College of Gastroenterology.
    Am J Gastroenterol; 1987 Jun; 82(6):504-6. PubMed ID: 2883885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.